Businessweek Archives

`Powerful Medicine' (European Business, Feb. 16) (Int'l Edition)


International -- Corrections & Clarifications

`Powerful medicine' (European Business, Feb. 16) (int'l edition)

In "Powerful medicine" (European Business, Feb. 16), the combined revenues of Glaxo Wellcome PLC and SmithKline Beecham PLC would be $26 billion. The combined research and development spending would be $1 billion more than what Novartis spends, not three times as much.


Toyota's Hydrogen Man
LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus